P. Dellamonica

10.4k total citations · 1 hit paper
333 papers, 7.0k citations indexed

About

P. Dellamonica is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, P. Dellamonica has authored 333 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Infectious Diseases, 130 papers in Epidemiology and 69 papers in Virology. Recurrent topics in P. Dellamonica's work include HIV/AIDS Research and Interventions (67 papers), HIV/AIDS drug development and treatment (66 papers) and HIV Research and Treatment (65 papers). P. Dellamonica is often cited by papers focused on HIV/AIDS Research and Interventions (67 papers), HIV/AIDS drug development and treatment (66 papers) and HIV Research and Treatment (65 papers). P. Dellamonica collaborates with scholars based in France, United States and Vietnam. P. Dellamonica's co-authors include J. Durant, Philippe Clevenbergh, R. Garraffo, Christian Pradier, Patrizia Carrieri, Bruno Spire, Philippe Halfon, N Montagne, Brigitte Dunais and E Bernard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

P. Dellamonica

321 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

1999 559 citations J. Durant, Philippe Halfon et al. profile →

Peers

Countries citing papers authored by P. Dellamonica

Since Specialization

Citations

This map shows the geographic impact of P. Dellamonica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dellamonica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dellamonica more than expected).

Fields of papers citing papers by P. Dellamonica

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Dellamonica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dellamonica. The network helps show where P. Dellamonica may publish in the future.

Co-authorship network of co-authors of P. Dellamonica

This figure shows the co-authorship network connecting the top 25 collaborators of P. Dellamonica. A scholar is included among the top collaborators of P. Dellamonica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Dellamonica. P. Dellamonica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adoption and Attitudes of eHealth Among People Living With HIV and Their Physicians: Online Multicenter Questionnaire Study 2020 ·JMIR mhealth and uhealth ·Christine Jacomet, Roxana Ologeanu‐Taddei, (unknown), Céline Lambert, (unknown), (unknown), P. Dellamonica	7
2	Yeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study 2013 ·Journal of Virological Methods ·Isabelle Ravaux, (unknown), (unknown), Jacqueline Cottalorda, J. Durant, P. Dellamonica, Pablo Gluschankof, Andréas Stein, Catherine Tamalet	6
3	Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study 2010 ·Arthritis Research & Therapy ·Mélanie Gilson, Laure Gossec, Xavier Mariette, (unknown), Marie-Hélène Guyot, Jean‐Marie Berthelot, Daniel Wendling, C. Michelet, P. Dellamonica, Florence Tubach, Maxime Dougados, Dominique Salmon	46
4	Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data 2009 ·Journal of Antimicrobial Chemotherapy ·Camélia Protopopescu, F. Raffi, Perrine Roux, Jacques Reynes, P. Dellamonica, Bruno Spire, C. Leport, Patrizia Carrieri, (unknown)	87
5	Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART) 2008 ·Drug and Alcohol Dependence ·Laurent Michel, Roch Giorgi, Virginie Villes, Isabelle Poizot‐Martin, P. Dellamonica, Bruno Spire, Camélia Protopopescu, Patrizia Carrieri	14
6	Skin Manifestations of West Nile Virus Infection 2005 ·Dermatology ·P. Del Giudice, I. Schuffenecker, H. Zeller, (unknown), F. Vandenbos, P. Dellamonica, E. Counillon	15
7	Impact of Various Antiretroviral Drugs and Their Plasma Concentrations on Plasma Lipids in Heavily Pretreated HIV-Infected Patients 2003 ·HIV Clinical Trials ·(unknown), R. Garraffo, P. Dellamonica	26
8	Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients 2002 ·HIV Clinical Trials ·(unknown), Éric Cua, (unknown), J. Durant, (unknown), Ronan Boulmé, Jacqueline Cottalorda, (unknown), Jonathan Schapiro, F Clavel, P. Dellamonica	14
9	[Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years]. 2002 ·PubMed ·Eugènia Mariné–Barjoan, Éric Fontas, Christian Pradier, Denis Ouzan, Marie‐Christine Saint‐Paul, (unknown), (unknown), James Boulant, (unknown), (unknown), (unknown), (unknown), Jean‐François Michiels, P. Dellamonica, Patrick Rampal, Albert Tran	2
10	Iatrogenic Cushing's Syndrome in an HIV-Infected Patient Treated with Inhaled Corticosteroids (Fluticasone Propionate) and Low Dose Ritonavir Enhanced PI Containing Regimen 2002 ·Journal of Infection ·(unknown), (unknown), (unknown), S. Hiéronimus, V. Mondain, R M Chichmanian, Jean‐Louis Sadoul, P. Dellamonica	38
11	Risk of invasive cervical cancer among women with, or at risk for, HIV infection 1999 ·International Journal of Cancer ·Diego Serraino, Patrizia Carrieri, Christian Pradier, Ettore Bidoli, Maria Dorrucci, (unknown), (unknown), (unknown), Patrizio Pezzotti, P. Dellamonica, Silvia Franceschi, Giovanni Rezza	84
12	New Perspectives Offered by a French Study of Antibiotic Resistance in Day-Care Centers 1998 ·Chemotherapy ·P. Dellamonica, Christian Pradier, Brigitte Dunais, (unknown)	8
13	High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV-infected patients 1998 ·Clinical Microbiology and Infection ·(unknown), J. Durant, Philippe Halfon, Albert Tran, (unknown), (unknown), Guangxiao Yang, Sylvia Benzaken, Denis Ouzan, Patrick Rampal, P. Dellamonica	4
14	Nasopharyngeal carriage of Streptococcus pneumoniae in children's day-care centers; 10-month follow-up study in Nice, France 1997 ·Clinical Microbiology and Infection ·Christian Pradier, Brigitte Dunais, R. Largillier, H. Carsenti-Etesse, E Bernard, (unknown), P. Dellamonica	12
15	[Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform]. 1988 ·PubMed ·(unknown), R. Garraffo, (unknown), Alexis M. Barbarin, E Bernard, P Lapalus, C Argenson, (unknown), P. Dellamonica	4
16	Cinétique de la diffusion de la péfloxacine dans le tissu osseux humain après perfusion unique de 800 mg. Evaluation de la technique d'extraction par le chloroforme. 1988 ·Pathologie Biologie ·(unknown), R. Garraffo, (unknown), Alexis M. Barbarin, E Bernard, (unknown), C Argenson, (unknown), P. Dellamonica	2
17	Effet de la rifampicine sur la pharmacocinétique de la doxycycline. 1987 ·Pathologie Biologie ·R. Garraffo, P. Dellamonica, Jean Fournier, P Lapalus, E Bernard, (unknown), R M Chichmanian	4
18	[Selection of mutant rifampin-resistant Staphylococcus aureus during the therapeutic use of this antibiotic in combinations. 3 cases]. 1983 ·PubMed ·P. Dellamonica, E M Bernard, (unknown), Y Brun	1
19	Facteurs discriminants du risque infectieux en chirurgie digestive réglée. Essai à propos de trois cent huit cas. 1982 ·Annales de Chirurgie ·P. Dellamonica, E Bernard, (unknown), Nicolas Etienne	1
20	Brucellose aiguë avec thrombopénie et anticorps cytotoxiques. 1982 ·La Nouvelle presse médicale ·P. Dellamonica, (unknown), E Bernard, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact